Deaths a ‘lagging indicator’ of Covid, will stabilise soon: Gagandeep Kang


India’s leading virologist Dr Gagandeep Kang has said that since the number of Covid-19 cases in the country has stabilized now, the number of deaths because of the virus will also stabilize soon and whether it fails to take action then it can only point to an issue with reporting systems.

Kang, a member of the Supreme Court-appointed committee on medical oxygen in an interview to ANI said, “Death is a lagging indicator, it comes two to three weeks after case numbers climb. Now that the numbers have stabilized, we will have to expect deaths to also stabilize and start to taper off. Whether they don’t, there is a matter with some aspect of our reporting systems.”

The virologist explained that having a look at the fatality rate isn’t a preferred way to measure the current spread of the pandemic as people dying are in most cases infected a minimum of two to three weeks earlier, because of this deaths don’t mirror current spread of the disease.

According to official data issued on Tuesday, India recorded 1,96,427 fresh infections and 3,741 deaths in the final 24 hours.

Regarding the scarcity of vaccines across the country, Dr Gagandeep Kang, who is advisor to the Punjab Chief Minister on Covid issues pointed out that vaccinations has slowed down because of slow or limited provide of vaccines, which will go up once companies ramp up their production.

Because of the shortfall of Covid-19 vaccines, several states like Maharashtra, Delhi and Karnataka have suspended their innocualtion drive agains the novel coronavirus for beneficiaries of the age group 18-44 years.

“Another choice would be to import vaccines whether we could. But globally there’s a scarcity of vaccines. The only options to be had are the Russians and the Chinese vaccines. We need to come to a decision, which one we are willing to shop for and get those in,” Kang said.

Currently, two Covid-19 vaccines are being manufactured in India – Covishield by Serum Institute of India (SII) and Covaxin by Bharat Biotech.

India started its Covid vaccination drive on January 16 for the healthcare and frontline workers. Phase 3 of the vaccination drive used to be started on May 1 for the beneficiaries of the age group 18-44 years.

(Only the headline and picture of this outline may have been reworked by the Trade Standard staff; the remainder of the satisfied is auto-generated from a syndicated feed.)

Dear Reader,

Trade Standard has at all times strived tough to supply up-to-date information and remark on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and fixed feedback on how to beef up our offering have only made our get to the bottom of and commitment to these ideals stronger. Even all through these difficult times arising out of Covid-19, we continue to remain dedicated to keeping you informed and up to date with credible news, authoritative views and incisive remark on topical issues of relevance.

We, on the other hand, have a request.

As we battle the economic affect of the pandemic, we need your improve even more, in order that we will be able to continue to give you more quality satisfied. Our subscription mannequin has seen an encouraging response from many of you, who have subscribed to our online satisfied. More subscription to our online satisfied can only help us achieve the goals of offering you even better and more applicable satisfied. We imagine in free, reasonable and credible journalism. Your improve through more subscriptions can help us practise the journalism to which we are dedicated.

Reinforce quality journalism and subscribe to Trade Standard.

Digital Editor

Top stories / News / Trade


Please enter your comment!
Please enter your name here